Reimbursed with a limitationGenericATC L01BC07

Azacitidin Viatris

Azacitidin Viatris is a generic from Viatris Pharma GmbH and is listed on the FOPH Specialities List. Basic health insurance reimburses it within the authorised indication. The public price ranges from CHF 259.95 to CHF 259.95 depending on the pack; the co-payment is 10 per cent.

Core data

Authorisation holder
Viatris Pharma GmbH
ATC code
L01BC07
IT group
07.16.10 Cytostatica
Active substances
Azacitidinum
Preparation type
Generic
On the SL since
01/05/2021
Last price change
01/05/2021
Co-payment
10%

Prices per pack

The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.

Azacitidin Viatris Price table As of 17/09/2026
Dosage formPack sizeEx-factory pricePublic priceValid fromCat.GTIN
Trockensub 100 mgDurchstf 1 StkCHF 224.25CHF 259.9501/11/2023A7680676760021

Limitation

This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.

The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.

FOPH wordingIndication 21235.02Valid from 01/05/2021

Behandlung von Patienten, die für eine Transplantation hämatopoetischer Stammzellen nicht geeignet sind und eines der folgenden Krankheitsbilder aufweisen:
- Myelodysplastisches Syndrom mit intermediärem oder hohem Risiko gemäss International Prognostic Scoring System (IPSS) vom Typ refraktäre Zytopenie mit multilineärer Dysplasie (RCMD) oder refraktäre Anämie mit 5-19% Knochenmarksblasten (RAEB I und II)
- Chronisch myelomonozytäre Leukämie
- Akute myeloische Leukämie (AML) mit 20-30% Knochenmarksblasten und Mehrlinien-Dysplasie (gemäss Klassifikation der World Health Organisation (WHO) 2008)
- Akute myeloische Leukämie (AML) mit >30% Knochenmarksblasten, gemäss Klassifikation der WHO, bei älteren Patienten, die für eine intensive Chemotherapie nicht geeignet sind oder diese nicht vertragen.

More preparations in this group

FAQ

Is Azacitidin Viatris covered by Swiss health insurance?

Yes, but only under conditions. Azacitidin Viatris is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.

What does Azacitidin Viatris cost in Switzerland?

The public price is the maximum price set by the FOPH and for Azacitidin Viatris ranges from CHF 259.95 to CHF 259.95 per pack. The ex-factory price ranges from CHF 224.25 to CHF 224.25. Pharmacies may not charge more, but may charge less.

Correct or complete this entry

Market access

Do you need your product on the Specialities List?

Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.

  • Independent directory
  • Official FOPH data
  • Website in eight languages
Send an enquiry
Contact

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissreimbursement.com